GILL, Jason,LOADMAN, Paul,Falconer, Robert,PATTERSON, Laurence,ATKINSON, Jennifer,Bibby, Michael
申请号：
DK12160565
公开号：
DK2481429T3
申请日:
2008.03.27
申请国别(地区):
DK
年份:
2018
代理人:
摘要：
The present invention relates to compounds, and pharmaceutically acceptable salts thereof, comprising a vascular disrupting agent (VDA) associated and a MMP proteolytic cleavage site. The compounds are useful in the treatment of cancer.
